ReviewMolecules (Basel, Switzerland)2020

Proanthocyanidins Should Be a Candidate in the Treatment of Cancer, Cardiovascular Diseases and Lipid Metabolic Disorder.

Tsz Ki Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.